EP2 Program Overview
Are you ready to attest for 2017 Meaningful Use (Promoting Interoperability) and receive your incentive from CMS? In July, the MEIPASS system launched and providers will only have until October 15, 2018 to collect their supporting information and attest for achieving 2017 Promoting Interoperability. Eligible providers, if they use an EHR to capture patient data, coordinate care of the patient, ePrescribe, and engage with patients via their ONC-certified EHR technology, can receive an $8500 per year incentive for each of up to four years of participation. Grant funded free technical services are available from Strategic Interests to assist with your current and future attestations for Stages 2 and 3.
About the Medicaid Eligible Professional Program (EP2) Program and Services Available
The Medicaid Eligible Professional Program (EP2) is a New York State Department of Health (DOH) initiative providing FREE outreach, assistance, and support services. In the Buffalo and Rochester areas, NYeC has selected Strategic Interests as the supporting Technical Agent to assist providers in achieving the various stages of Promoting Interoperability. These free EP2 Services include:
Audit Readiness and Preparation
SI is currently enrolling organizations and practices. Enrollment is a simple two-step process:
Filling out/confirming a list of the eligible providers in a spreadsheet-based roster
Completion, with single signing authority, an electronic Practice Participation Agreement/Business Associate Agreement. This will be done through Docu-Sign.
Attached is a summary of the program and a comparison of the Stage 2 and Stage 3 objectives.
For more information or to enroll, reply to this email at EP2@strategicinterests.com. If you’d like, we could set up a videoconference call with you or representatives from the practice to review the program and answer any questions. Please let us know your immediate availability and we will work to accommodate. On behalf of the SI EP2 team, we look forward to speaking with you.